Article type
Abstract
"Background: Evidence Mapping makes evidence more easily accessible and discoverable for patients, public and knowledge users like funders and decisionmakers. They are increasingly conducted in areas relevant to Campbell, Cochrane, JBI and GIN. Despite the explosion in mapping reviews in the last five years, there exists a notable absence of reporting standards or guidelines specific to mapping reviews.
Objectives: This project aims to address this gap by developing a comprehensive reporting guideline for mapping reviews.
Methods: The development of the Preferred Reporting Items for Evidence Mapping (PRITEM) guideline will follow Moher et al guidance consisting of seven key steps: 1. identify the need, 2. obtain funding and register protocol, 3. establish working groups, 4. review the literature, 5. Delphi process, 6. consensus meeting, and 7. dissemination. We have established an advisory board with six members from the Campbell Collaboration, 3ie, JBI, and Lanzhou University. For step 4, we are conducting two scoping reviews following JBI methodology. The first scoping review will assess all existing guidance on mapping reviews and methodological research, and the second will be a purposive sample of 200 mapping reviews to assess reporting characteristics. We searched nine electronic databases and 11 institutional websites from inception to Jan, 2024. We included all mapping reviews focused on health or social sectors.
Results: For the scoping reviews, we identified 28,344 relevant records. Following screening, 465 mapping reviews were eligible. Subsequently, we plan to employ a stratified randomization based on research fields to select 200 mapping reviews. This subset will be thoroughly examined to investigate specific reporting characteristics within the chosen studies. Additionally, 111 related guidance or methodological studies are undergoing full-text screening. Full results of these two scoping reviews will be presented. The PRITEM project will be completed by October 2024.
Conclusions: The PRITEM guidance on mapping reviews will serve as a valuable resource for developers of mapping reviews, thus enhancing the overall reporting quality of mapping reviews and reducing research waste. "
Objectives: This project aims to address this gap by developing a comprehensive reporting guideline for mapping reviews.
Methods: The development of the Preferred Reporting Items for Evidence Mapping (PRITEM) guideline will follow Moher et al guidance consisting of seven key steps: 1. identify the need, 2. obtain funding and register protocol, 3. establish working groups, 4. review the literature, 5. Delphi process, 6. consensus meeting, and 7. dissemination. We have established an advisory board with six members from the Campbell Collaboration, 3ie, JBI, and Lanzhou University. For step 4, we are conducting two scoping reviews following JBI methodology. The first scoping review will assess all existing guidance on mapping reviews and methodological research, and the second will be a purposive sample of 200 mapping reviews to assess reporting characteristics. We searched nine electronic databases and 11 institutional websites from inception to Jan, 2024. We included all mapping reviews focused on health or social sectors.
Results: For the scoping reviews, we identified 28,344 relevant records. Following screening, 465 mapping reviews were eligible. Subsequently, we plan to employ a stratified randomization based on research fields to select 200 mapping reviews. This subset will be thoroughly examined to investigate specific reporting characteristics within the chosen studies. Additionally, 111 related guidance or methodological studies are undergoing full-text screening. Full results of these two scoping reviews will be presented. The PRITEM project will be completed by October 2024.
Conclusions: The PRITEM guidance on mapping reviews will serve as a valuable resource for developers of mapping reviews, thus enhancing the overall reporting quality of mapping reviews and reducing research waste. "